Dra. María Natalia Gandur Quiroga
@nataliagandur
Leader GU @InstitutoRoffo #GU #RCC #prostate #bladder #testis #GUcsm #clinicaltrials #Immunotherapy #PrecisionMedicine #OncoAlert #OncoReporte
Views Mine
ID:1001912023750529024
30-05-2018 19:43:35
4,6K Tweets
1,7K Followers
943 Following
Follow People
Toni Choueiri, MD
Senior Executive & Chief GU Cancers @DanaFarber; Prof Medicine @HarvardMed; 2021 Giants of Cancer Award ⚽ lover; 🚲@PanMass, seen on @msnbc @cnn @TODAYshow @GMA
Enrique Grande
Jefe del Servicio de #Oncología Médica y Director de Investigación Clínica de la Fundación MD Anderson Cancer Center Madrid. Opinions are my own
Petros Grivas
Oncologist, Professor, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch; views are mine
FLoscoMD
Uro Oncology Journey is the reward Buenos Aires Argentina
Martín Angel
Oncólogo Clínico staff @IAF_Fleming. Miembro @SelnetH2020 @aaoncoclinica. Interesado en #GUcsm. #clinicaltrials. #Immunotherapy #PrecisionMedicine #oncoalert
💫🌟Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The #EMBARK Trial
📚 Authors: David Einstein, Meredith Regan, ScD, Julia S. Stevens, David F. @McDermott, Ravi A Madan M.D..
OncoAlert
🔍 Key findings
🔬 PSA detects micrometastatic
💫🌟🚨 The OncoAlert NEWSLETTER is here! 🚨🌟💫
🗓️ Covering May 9-16, 2024
🔗 REGISTER at OncoAlert360.com or oncoalert.m-pages.com/nhMpwe/oncoale…
What's inside:
🌟 CheckMate77T #LungCancer 🫁
🌟 IMpassion132 #BreastCancer #ESMOBreast24
🌟 MARS2
🌟 DESTINY-Gastric01 #GastricCancer
Excited to join Total Health in partnership with HSCO and the University of Hawai'i Cancer Center as a speaker at their upcoming 2024 ASCO Direct Hawaii Conference!
Register Free Today: totalhealthoncology.com/ascohawaii
Total Health | Oncology 📖🔬 Oncology State Societies at ACCC University of Hawaii Cancer Center
💫🌟🚨 Countdown Alert: Just two weeks!! to go until #ASCO24 !
🌐 The OncoAlert team is all set to bring the latest in oncology from around the globe!
🇦🇷 Dra. María Natalia Gandur Quiroga
🇫🇷 Alizée Camps - - Maléa
🇮🇹 Marta Perachino
🇩🇪 Kathrin Heinrich
🇺🇸 Biagio Ricciuti, MD PhD
🇹🇷 Deniz Can Guven
🇺🇸 Emre Yekedüz
What’s happening with mHSPC in China? GU Cast has a special focus on China with Yao Zhu and Ning Zhang. Epidemiology, staging, management - what can we learn Declan Murphy Renu Eapen youtu.be/Llbt2pArlPI?si…
⚡️ Association Between GLP1R Agonists and Prostate, Kidney, and Bladder Cancers
#BladderCancer #KidneyCancer
European Urology OncoAlert
euoncology.europeanurology.com/article/S2588-…
The OncoAlert🚨NEWSLETTER OUT
Covering May 2-8, 2024
REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…
✅ The Lancet Commission on #ProstateCancer
✅DESTINY-PanTumor01
✅Osimertinib+Local tx for brain🧠mets in EGFRm #NSCLC 🫁
✅ASCENT in Triple Negative
The Lancet Commission highlights the urgent need to address the projected doubling of global #ProstateCancer cases by 2040
Doing so by:
✅Early diagnosis strategies
✅Equitable access to care
✅increased research focus on ethnic disparities and treatment distribution in LMICs
Our efforts to find optimal combinations with fewer adverse events while maintaining effectiveness for our patients continue.
We are extremely pleased to be involved in this study as Ankara Üniversitesi
Thank you dear Neeraj Agarwal, MD, FASCO for presenting at #AUA24
OncoAlert Arun Azad
💫🌟🔬 Exciting updates from #AUA24 ! Dr. Neeraj Agarwal Neeraj Agarwal, MD, FASCO unveils
🆕️EvoPAR-Prostate01 phase 3 trial for mHSPC #ProstateCancer .🌟💫 Exploring ADT+ARPI with/without SARUPARIB, a groundbreaking PARP1 inhibitor. Dive into the trial design 👇🔥 Amer. Urol. Assn. OncoAlert
